Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma

<table>Marked escalation of serum chromogranin A levels 4 months after initial sampling on proton pump inhibitor rapid normalisation after 3 weeks of its withdrawal.</table>

Case Reports in Endocrinology

fig1

Figure 1

Figure 1: Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma 

Figure 1 | Malignant Range Elevation of Serum Chromogranin A due to Inadvertent Use of Proton Pump Inhibitor in a Subject with Pancreatic Incidentaloma 